Developing a cell and gene therapy packaging strategy
By Scott Sznyter
Published in: Pharma Manufacturing
Published on: August 15, 2022
Demand for viral vectors used for cell and gene therapies (CGT) is increasing dramatically as hundreds of these novel treatments advance through the clinic towards commercialization. Many challenges must be overcome to ensure the cost-effective manufacturing of these complex biomolecules, including selecting the right solutions for packaging, storage and transport of these expensive and potentially lifesaving products.
If you have not yet signed up for the StabilityHub newsletter, join hundreds of other stabilitarians to get the latest news, publications, job opportunities and more!
By submitting this form, you are consenting to receive emails from: StabilityHub, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact